AzTrials
AzTrials

Rheumatoid ArthritisBETTER DietNCT05772325

The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease

A study testing Individually tailored diet counseling and The brief standardized 4-minute heart healthy dietary advice in people with Rheumatoid Arthritis and Psoriatic Arthritis, run by Diakonhjemmet Hospital at 1 site in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

A randomized controlled study comparing brief dietary intervention with a personal, tailored dietary advice (60 min) on change in LDL-c and change in diet. Read more about this study

Who is it for?
Ages 30 to 80 yearsHealthy volunteers can take part
What is being tested?
Individually tailored diet counseling and The brief standardized 4-minute heart healthy dietary advice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteNorway
Study dates
20 Feb 2023to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients with either RA, PsA, or AS, between 30-80 years with an increased risk of future CVD, estimated using the CVD risk calculator. i.e. any risk \> 5 -10 % predicted by Systematic Coronary Risk Evaluation (SCORE2) algorithm. Also, patients with very high risk (predicted risk \>10%) as well as established atherosclerotic CVD (ASCVD) including previous myocardial infarction, coronary intervention (coronary artery bypass grafting or percutaneous coronary intervention), transient ischemic attack/strokes, atherosclerotic diseases of arteries as in the carotid artery or peripheral arterial disease (PAD) will also be included.

Who cannot join

  • Heart failure with systolic EF\<40%
  • Kidney failure with GFR \< 35
  • Liver failure
  • Mental disorder rendering the patient unable to comply with the protocol
  • Being able to speak the language of the country
  • Reduced cognitive function
  • Substance abuse
  • Recent initiation or change in doses of lipid-lowering therapy or weight loss medication

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Diakonhjemmet Hospital

    Oslo, 0370

Other trials in Norway

About this study

Official title: The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease "The Diet Study"

A randomized controlled study comparing brief dietary intervention with a personal, tailored dietary advice (60 min) on change in LDL-c and change in diet.

Read the detailed description

Patients with inflammatory joint diseases (IJD) as rheumatoid arthritis (RA), spondylo arthropathy (SpA) and psoriatic arthritis (PsA) are at high risk of atherosclerotic cardiovascular disease. International recommendations for the prevention of cardiovascular disease recommend smoking cessation, physical activity, and dietary changes as part of treatment. Despite the evidence that behavioral counseling reduces overall cardiovascular risk, it is often an overlooked and underemphasized by clinicians. As of today, there is a knowledge gap regarding the efficacy of less intensive counseling sessions needed to obtain changes in dietary habits and clinical effects on CVD risk factors. Therefore, a brief dietary advice would be preferable if it could give a positive change in dietary habits and cholesterol. We have previously shown in a pilot study (8) that a 4 min. brief advice compared to a 60 min. personal tailored advice by a dietician on heart-friendly diet gave a similar change in dietary habits and LDL-c after 8 weeks in patients with IJD. The aim of the Diet Study is to perform a randomized controlled study comparing brief intervention (4 min) with a personal tailored dietary advice (60 min) on change in LDL-c and change in diet.

Being tested
Individually tailored diet counseling, The brief standardized 4-minute heart healthy dietary advice
Medical subject headings
Arthritis, Rheumatoid, Arthritis, Psoriatic, Spondylarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individually tailored diet counselingOther

    Participants in the intervention group will receive a 60 min individually tailored heart-friendly diet consultation by a dietitian

  • The brief standardized 4-minute heart healthy dietary adviceOther

    The brief standardized 4-minute heart healthy dietary advice will be provided by an experienced cardiologist or rheumatologists

Study groups in NCT05772325
Study groupRoleWhat they receive
Brief standardized dietary adviceActive comparatorThe brief standardized 4-minute heart healthy dietary advice will be provided by an experienced cardiologist or rheumatologists.
Receives: Other: The brief standardized 4-minute heart healthy dietary advice
Individually tailored diet counselingExperimentalParticipants in the intervention group will receive a 60 min individually tailored heart-friendly diet consultation by a dietitian.
Receives: Other: Individually tailored diet counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. LDL cholesterol change from baseline

    LDL cholesterol change from baseline

    Measured: 8 weeks

Secondary outcomes (1)
  1. Change in Healthy Diet Score (HDS) according to SmartDiet score

    A self-administered 15-item food-frequency questionnaire (SmartDiet™) will be applied to assess subjects' average intake of: dairy products, mayonnaise products, meat, grain, fish, fruit, vegetables and snacks. The questionnaire has three response categories: Least healthy (1 point), Medium healthy (2 points) and Most healthy (3 points). The scores on the 15 questions are summed to obtain a Healthy Diet Score (HDS) ranging from 15 (worst) to 45 points (best). A change in the sum score of > 3 is considered a (clinical) significant change in diet.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2023
  2. Study start20 Feb 2023
  3. Primary completion1 Aug 2026 (estimated)
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05772325
Sponsor's protocol ID
Protocol 01.01.25
Acronym
BETTER Diet
Status last verified
Jul 2026
First submitted
6 Mar 2023
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Individually tailored diet counseling and The brief standardized 4-minute heart healthy dietary advice in people with Rheumatoid Arthritis and Psoriatic Arthritis, run by Diakonhjemmet Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

LDL cholesterol change from baseline (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in